TheEdgeResearch
Home / Stocks / SNNVF

Sunniva Inc. (SNNVF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$3,921
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.01
52-Wk Range
0.00001-0.0001
CEO
Anthony F. Holler
Country
CA
Currency
USD

Sunniva Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $3,921. On trailing twelve-month figures it carries a trailing P/E of -0.17, a net margin of -154.6%. Its beta of 0.01 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.17
Price / Sales
0.32
Price / Book
0.06
EV / EBITDA
-1.08
Gross margin
41.5%
Operating margin
-149.7%
Net margin
-154.6%
Return on equity
—
Debt / equity
0.28
Current ratio
0.93
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
148
IPO date
2018-01-11
Headquarters
Vancouver, BC, CA
About Sunniva Inc.

Sunniva Inc. is a fully integrated cannabis enterprise that specializes in the comprehensive development of therapeutic cannabis solutions, from cultivation and production to final distribution, primarily serving markets in Canada and the United States. The company organizes its operations into three distinct areas: Patient Counselling, Merchandising, and Cultivation & Extraction. Its product line is marketed under specific brand names, including Sun Fire, Kyndness, and Herbella. Originally founded in 2014 as Sunniva Holdings Corp., the firm officially adopted the name Sunniva Inc. in August 2017. The company's headquarters are situated in Vancouver, Canada.

Comparable companies

Sunniva Inc. is most often compared with the following Healthcare names:

CANSFCXXIFDXBRFELIXFFLOOFMILFFMRMDSPBBFTCNAFVEXTF
More research on SNNVF
SNNVF technical analysis SNNVF TheEdge Score Compare against peers
Open full interactive analysis & DCF →